Nonparametric density estimation applied to population pharmacokinetics
Related Experiment Video
Updated: Aug 12, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Abstract:
Kinetic parameters are estimated to assess absorption, distribution, metabolism, and elimination of a drug in a subject. In a group of subjects, pharmacokinetic population studies are developed to describe the variability and to detect particular subsets by establishing the relationships between kinetic parameters and easily measurable subject characteristics, the covariates (age, body weight, etc.). The usually proposed methods are based on linear regression equations relating kinetic parameters to the covariates. We propose to measure these dependencies and describe the interindividual variability through the joint probability density function. This function is estimated by a nonparametric method superposing potential functions or kernels over the sample. In this estimation, the Shannon information theory was applied to determine the number of individuals needed to describe the variability reliably and to screen informative covariates with respect to the kinetic parameters. This approach was used to obtain the nonparametric conditional probability density functions of the kinetic parameters, given the covariates. These functions supplied prior information for a Bayesian estimation. The feasibility of the global approach was illustrated by a simulation in which nonlinear relations link covariates and pharmacokinetic parameters. The performance of this new estimator using covariates was compared with that of the usual Bayesian estimation.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
Dosage Regimens: Partial Pharmacokinetic Parameters

